FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313461289> ?p ?o ?g. }

• W4313461289 abstract "Introduction Adherence to tuberculosis (TB) medication is one of the critical challenges to tuberculosis elimination in India. Digital adherence technologies (DAT) have the potential to facilitate medication adherence and monitor it remotely. Tuberculosis Monitoring Encouragement Adherence Drive (TMEAD) is one such DAT piloted in Nasik, Maharashtra, from April 2020 to December 2021. The study aims to assess the adherence and cost-effectiveness of TMEAD compared to the standard of care among patients with drug-sensitive tuberculosis (DSTB) residing in the urban areas of Nasik, Maharashtra, India. Methods A quasi-experimental study was conducted among new cases of TB as per the National TB Elimination Programme (NTEP) residing in the urban geography of Nasik. The intervention and control arms were purposively selected from non-contaminating TB units (TUs). A total of 400 DSTB patients (200 in the intervention group and 200 in the control group) were enrolled. After enrolment, patients in the intervention arm were provided with the TMEAD device and followed for 24 weeks to assess treatment outcomes. Adherence was measured as those patients who have completed 80% of prescribed doses, as reported during patient follow-up, and further validated by analyzing the trace of rifampicin in urine among 20% of patients from both arms. A budget impact analysis was done to assess the impact of the TMEAD program on the overall state health budget. Results Out of 400 enrolled DSTB patients, 261 patients completed treatment, 108 patients were on treatment, 15 patients died, and 16 patients were defaulters over the study period. The study reported overall treatment adherence of 94% among those who completed treatment. Patient reports indicated high levels of treatment adherence in the intervention group (99%) as compared to the control group (90%). Adherence assessed through analyzing trace of rifampicin in the urine sample for the intervention arm was 84% compared to the control arm (80%). Per beneficiary (discounted) cost for TMEAD was Indian rupees (INR) 6,573 (USD 83). The incremental cost-effectiveness ratio of the intervention is INR 11,599 (USD 146), which shows that the intervention is highly cost-effective. Conclusion This study revealed that patient-reported treatment adherence was high in TMEAD when compared to standard therapy of care for DSTB patients and the intervention is cost-effective. TMEAD could complement the national strategy to end TB by improving adherence to the treatment regimen in India." @default.
• W4313461289 created "2023-01-06" @default.
• W4313461289 creator A5002397886 @default.
• W4313461289 creator A5002947854 @default.
• W4313461289 creator A5003329858 @default.
• W4313461289 creator A5018190629 @default.
• W4313461289 creator A5024422314 @default.
• W4313461289 creator A5033751834 @default.
• W4313461289 creator A5035635790 @default.
• W4313461289 creator A5050572720 @default.
• W4313461289 creator A5064795424 @default.
• W4313461289 creator A5065670860 @default.
• W4313461289 creator A5070797151 @default.
• W4313461289 creator A5071118942 @default.
• W4313461289 creator A5091908644 @default.
• W4313461289 date "2022-12-21" @default.
• W4313461289 modified "2023-09-26" @default.
• W4313461289 title "Tuberculosis Monitoring Encouragement Adherence Drive (TMEAD): Toward improving the adherence of the patients with drug-sensitive tuberculosis in Nashik, Maharashtra" @default.
• W4313461289 cites W1537598136 @default.
• W4313461289 cites W1831649821 @default.
• W4313461289 cites W1845225129 @default.
• W4313461289 cites W1925415092 @default.
• W4313461289 cites W1975018794 @default.
• W4313461289 cites W2002976202 @default.
• W4313461289 cites W2113152977 @default.
• W4313461289 cites W2125168028 @default.
• W4313461289 cites W2396062535 @default.
• W4313461289 cites W2422419784 @default.
• W4313461289 cites W2765846704 @default.
• W4313461289 cites W2784272297 @default.
• W4313461289 cites W2810683857 @default.
• W4313461289 cites W2896055019 @default.
• W4313461289 cites W2896207696 @default.
• W4313461289 cites W2912724961 @default.
• W4313461289 cites W2981527572 @default.
• W4313461289 cites W2996375518 @default.
• W4313461289 cites W3022003189 @default.
• W4313461289 cites W3171941571 @default.
• W4313461289 doi "https://doi.org/10.3389/fpubh.2022.1021427" @default.
• W4313461289 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36620234" @default.
• W4313461289 hasPublicationYear "2022" @default.
• W4313461289 type Work @default.
• W4313461289 citedByCount "1" @default.
• W4313461289 countsByYear W43134612892023 @default.
• W4313461289 crossrefType "journal-article" @default.
• W4313461289 hasAuthorship W4313461289A5002397886 @default.
• W4313461289 hasAuthorship W4313461289A5002947854 @default.
• W4313461289 hasAuthorship W4313461289A5003329858 @default.
• W4313461289 hasAuthorship W4313461289A5018190629 @default.
• W4313461289 hasAuthorship W4313461289A5024422314 @default.
• W4313461289 hasAuthorship W4313461289A5033751834 @default.
• W4313461289 hasAuthorship W4313461289A5035635790 @default.
• W4313461289 hasAuthorship W4313461289A5050572720 @default.
• W4313461289 hasAuthorship W4313461289A5064795424 @default.
• W4313461289 hasAuthorship W4313461289A5065670860 @default.
• W4313461289 hasAuthorship W4313461289A5070797151 @default.
• W4313461289 hasAuthorship W4313461289A5071118942 @default.
• W4313461289 hasAuthorship W4313461289A5091908644 @default.
• W4313461289 hasBestOaLocation W43134612891 @default.
• W4313461289 hasConcept C126322002 @default.
• W4313461289 hasConcept C142724271 @default.
• W4313461289 hasConcept C159110408 @default.
• W4313461289 hasConcept C160735492 @default.
• W4313461289 hasConcept C162324750 @default.
• W4313461289 hasConcept C187212893 @default.
• W4313461289 hasConcept C194828623 @default.
• W4313461289 hasConcept C2776967927 @default.
• W4313461289 hasConcept C2778607973 @default.
• W4313461289 hasConcept C2780665704 @default.
• W4313461289 hasConcept C2781069245 @default.
• W4313461289 hasConcept C50522688 @default.
• W4313461289 hasConcept C512399662 @default.
• W4313461289 hasConcept C71924100 @default.
• W4313461289 hasConcept C99454951 @default.
• W4313461289 hasConceptScore W4313461289C126322002 @default.
• W4313461289 hasConceptScore W4313461289C142724271 @default.
• W4313461289 hasConceptScore W4313461289C159110408 @default.
• W4313461289 hasConceptScore W4313461289C160735492 @default.
• W4313461289 hasConceptScore W4313461289C162324750 @default.
• W4313461289 hasConceptScore W4313461289C187212893 @default.
• W4313461289 hasConceptScore W4313461289C194828623 @default.
• W4313461289 hasConceptScore W4313461289C2776967927 @default.
• W4313461289 hasConceptScore W4313461289C2778607973 @default.
• W4313461289 hasConceptScore W4313461289C2780665704 @default.
• W4313461289 hasConceptScore W4313461289C2781069245 @default.
• W4313461289 hasConceptScore W4313461289C50522688 @default.
• W4313461289 hasConceptScore W4313461289C512399662 @default.
• W4313461289 hasConceptScore W4313461289C71924100 @default.
• W4313461289 hasConceptScore W4313461289C99454951 @default.
• W4313461289 hasFunder F4320335358 @default.
• W4313461289 hasLocation W43134612891 @default.
• W4313461289 hasLocation W43134612892 @default.
• W4313461289 hasLocation W43134612893 @default.
• W4313461289 hasLocation W43134612894 @default.
• W4313461289 hasOpenAccess W4313461289 @default.
• W4313461289 hasPrimaryLocation W43134612891 @default.
• W4313461289 hasRelatedWork W1896292939 @default.
• W4313461289 hasRelatedWork W1967225140 @default.
• W4313461289 hasRelatedWork W2003217209 @default.
• W4313461289 hasRelatedWork W2140892120 @default.

• next